Innovative Research Award
Joseph Saddik
Pfizer
Joseph Saddik, affiliated with Pfizer in the United States, is presented in connection with the Innovative Research Award at the International Innovator Awards. The supplied research-profile information identifies a Scopus author record with 2 indexed documents, 25 citations, and an h-index of 2. These bibliometric indicators provide a quantitative description of the research output represented in the cited author record; they should be interpreted within the context of publication volume, field, career stage, and citation practices. [1]
Abstract
This academic recognition profile documents the association of Joseph Saddik with the Innovative Research Award at the International Innovator Awards. The profile identifies Pfizer as the researcher’s institutional affiliation and the United States as the associated country. According to the supplied Scopus profile information, the author record contains 2 documents, 25 citations, and an h-index of 2. The listed subject area is Toxicology and Pharmaceutical Science. Bibliometric indicators such as publication counts, citation counts, and the h-index are commonly used to describe aspects of scholarly visibility and research output, although they do not independently capture the full range of research quality, originality, methodological contribution, or societal relevance. [1]
Keywords
Joseph Saddik; Innovative Research Award; Pfizer; Toxicology; Pharmaceutical Science; Scopus; h-index; citation analysis; scholarly research; International Innovator Awards.
Introduction
Research in toxicology and pharmaceutical science encompasses the investigation of substances, biological responses, therapeutic agents, safety profiles, mechanisms of action, and related questions relevant to biomedical and pharmaceutical development. Researchers working in these areas may contribute through experimental studies, translational research, analytical approaches, drug development activities, safety assessment, or interdisciplinary collaborations. [3]
Research Profile
The available profile identifies Joseph Saddik as a researcher affiliated with Pfizer in the United States, with a Scopus Author ID of 57223125865. The indexed record supplied for this article contains 2 documents and 25 citations, resulting in a reported h-index of 2.These figures describe the indexed record available through the specified author profile and should not be interpreted as a complete representation of every research activity, publication, collaboration, technical contribution, or professional responsibility. [2]
Research Contributions
The supplied subject classification places the profile within Toxicology and Pharmaceutical Science. Within these broad areas, research contributions can encompass the study of pharmacological and toxicological mechanisms, pharmaceutical development, drug safety, biological responses, analytical investigation, and the evaluation of compounds or therapeutic approaches. Specific contributions should be assessed from the underlying publications, datasets, experimental methods, patents, collaborations, and other documented research outputs rather than inferred solely from bibliometric indicators. [1]
Publications
The supplied profile records 2 documents in Scopus. Because publication titles, journal information, publication years, DOI identifiers, and complete bibliographic records were not supplied as part of the profile data, individual publications are not enumerated here. This approach avoids attributing publications to the researcher without sufficient bibliographic verification. [4]
Research Impact
The supplied citation count of 25 indicates that the indexed documents associated with the specified Scopus author record have received 25 citations according to the provided profile information. Citation counts can provide evidence of scholarly attention, but their interpretation depends on factors including discipline, publication age, document type, collaboration patterns, and citation practices. Consequently, citation metrics are most appropriately considered alongside qualitative evidence of research contributions and application.[2]
Award Suitability
Joseph Saddik is presented in this profile in connection with the Innovative Research Award at the International Innovator Awards. The supplied record identifies a professional affiliation with Pfizer, a research area in Toxicology and Pharmaceutical Science, 2 Scopus-indexed documents, 25 citations, and an h-index of 2. These documented elements can form part of an academic recognition profile. [3]
Conclusion
The available information presents Joseph Saddik as a researcher affiliated with Pfizer in the United States and associated with the subject area of Toxicology and Pharmaceutical Science. The supplied Scopus metrics comprise 2 documents, 25 citations, and an h-index of 2. The profile also includes an ORCID identifier that can assist with researcher identification and scholarly record linkage. [1]
External Links
References
- Elsevier. (2026). Scopus author details: Joseph Saddik, Author ID 57223125865. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57223125865
- Joseph Saddik. (2008). Predicting and Mitigating Sticking in High-Drug-Load Acetaminophen Tablets Using a Powder Rheology-Compression Approach
https://www.mdpi.com/2674-0516/5/3/31
- ORCID. (2026). Joseph Saddik ORCID record: 0000-0003-1490-9517. ORCID.
https://orcid.org/0000-0003-1490-9517
- International Innovator Awards. (2026.). International Innovator Awards.
https://innovatorawards.org/